Table 2.
Insulin resistance, glycemic control, and medication type in patients with respect to seropositivity for HP.
| Parameter | HP− | HP+ | P value | |
|---|---|---|---|---|
| Serum insulin (μIU/mL) | Nondiabetic | 11.65 ± 4.88 | 12.71 ± 4.64 | 0.708 |
| Diabetic | 6.97 ± 2.64 | 10.12 ± 4.72 | 0.002 | |
| HOMA-IR score | Nondiabetic | 2.74 ± 2.18 | 3.01 ± 2.12 | 0.704 |
| Diabetic | 3.16 ± 2.32 | 4.48 ± 2.78 | 0.013 | |
| FBS (mg/dL) | Nondiabetic | 92.75 ± 11.70 | 92.58 ± 14.92 | 0.915 |
| Diabetic | 173.43 ± 61.32 | 180.12 ± 64.27 | 0.468 | |
|
| ||||
| Lipid profile | ||||
| HDL (mg/dL) | Nondiabetic | 54.23 ± 19.79 | 56.55 ± 20.05 | 0.390 |
| Diabetic | 69.2 ± 29.2 | 60.7 ± 26.7 | 0.037 | |
| LDL (mg/dL) | Nondiabetic | 83.26 ± 29.75 | 85.96 ± 32.67 | 0.525 |
| Diabetic | 107.1 ± 43.2 | 116.0 ± 51.7 | 0.212 | |
| TG (mg/dL) | Nondiabetic | 142.63 ± 112.27 | 140.81 ± 95.20 | 0.897 |
| Diabetic | 224.2 ± 100.2 | 229.3 ± 114.6 | 0.747 | |
| Cholesterol (mg/dL) | Nondiabetic | 161.16 ± 42.68 | 157.50 ± 38.86 | 0.509 |
| Diabetic | 205.1 ± 63.2 | 207.3 ± 67.4 | 0.8 | |